Regeneron was up 4.7% at $813.38. If the gains hold, the stock will notch its highest close since Nov. 12, 2024, when it ...

What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) jumped 2.9% in the morning session after Bank of America Securities upgraded its rating on the company's stock from 'Underperform' to ...

In terms of liquidity and interest, the mean open interest for Regeneron Pharmaceuticals options trades today is 96.18 with a ...

Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment?

Bank of America has shifted its stance on Regeneron, raising the stock two notches to Buy from Underperform and lifting its price objective to $860 in a note on Wednesday.

Regeneron Pharmaceuticals Inc. stock reached a significant milestone, hitting a 52-week high of $795.88. This achievement underscores a positive trend for the biotechnology company, reflecting a ...

Recently, Regeneron Pharmaceuticals saw a wave of analyst upgrades from major banks such as Bank of America Securities and ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Regeneron Pharmaceuticals Inc. closed 2.05% short of its 52-week high of $792.77, which the company reached on December 24th.

Regeneron Pharmaceuticals Inc. closed 3.73% below its 52-week high of $792.77, which the company achieved on December 24th.